GMP facility investment plan hits snag

Published: 2007-10-05 07:00:00

Updated: 2007-10-05 07:00:00

A number of small-medium sized pharmaceutical firms are showing their reluctance to invest in GMP facilities to meet the new regulations governing current good manufacturing procedure (cGMP) and validation, as the detailed guideline on tax benefits of GMP facility investment has yet to be outline...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK